2016-01-22 | Lower Price Target | Needham & Company LLC | Buy | $6.00 to $3.00 |
2016-01-21 | Lower Price Target | RBC Capital | Sector Perform | $1.60 to $1.00 |
2016-01-21 | Lower Price Target | Royal Bank Of Canada | Sector Perform | $1.60 to $1.00 |
2015-12-02 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2015-09-24 | Lower Price Target | RBC Capital | Sector Perform | $3.50 to $3.00 |
2015-09-24 | Reiterated Rating | William Blair | Buy | $6.00 |
2015-08-17 | Lower Price Target | Needham & Company LLC | Buy | $7.00 to $6.00 |
2015-07-14 | Reiterated Rating | William Blair | Outperform | $5.00 to $6.00 |
2015-06-26 | Reiterated Rating | William Blair | Outperform | $5.00 |
2015-03-30 | Lower Price Target | Needham & Company LLC | Buy | $14.00 to $7.00 |
2014-12-30 | Set Price Target | William Blair | Buy | $8.00 to $4.00 |
2014-12-19 | Set Price Target | Needham & Company LLC | Buy | $14.00 |
2014-04-29 | Downgrade | Needham | Strong Buy to Buy | $30 to $14 |
2014-04-29 | Lower Price Target | Stifel Nicolaus | Buy | $21.00 to $9.00 |
2014-04-29 | Downgrade | RBC Capital | Outperform to Sector Perform | $19.00 to $4.50 |
2014-04-28 | Downgrade | Needham & Company LLC | Strong-Buy to Buy | $30.00 to $14.00 |
2014-02-27 | Initiated Coverage | CRT Capital | Buy | $20.00 |
2013-11-08 | Lower Price Target | Stifel Nicolaus | Buy | $26.00 to $21.00 |
2013-10-28 | Upgrade | Needham & Company LLC | Buy to Strong-Buy | $20.00 to $30.00 |
2009-12-22 | Reiterated | Wedbush Morgan | Outperform | $40 to $56 |
2009-09-21 | Initiated | RBC Capital Mkts | Outperform | |
2009-08-25 | Initiated | Thomas Weisel | Overweight | |
2009-05-14 | Initiated | Rodman & Renshaw | Mkt Outperform | $15 |
2008-09-19 | Initiated | RBC Capital Mkts | Outperform |
2016-01-22 | Lower Price Target | Needham & Company LLC | Buy | $6.00 to $3.00 |
2016-01-21 | Lower Price Target | RBC Capital | Sector Perform | $1.60 to $1.00 |
2016-01-21 | Lower Price Target | Royal Bank Of Canada | Sector Perform | $1.60 to $1.00 |
2015-12-02 | Downgrade | Stifel Nicolaus | Buy to Hold | |
2015-09-24 | Lower Price Target | RBC Capital | Sector Perform | $3.50 to $3.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In OGXI 0 funds of 2213 total. Show all
Fund name | Ticker shares |
---|
Name Relationship | Total Shares | Holding stocks |
---|---|---|
H.I.G. ONCOGENEX, INC. | 2.58% (545512) | OGXI / |
Clarke Anthony Chief Scientific Officer | 0.83% (176418) | OGXI / |
Stewart Richard Alistair President & CEO | 0.83% (176418) | OGXI / |
JACOBS CINDY EVP, CMO | 0.42% (89359) | OGXI / |
Clendeninn Neil James | 0.11% (22421) | HRTX / OGXI / |
Brady Patrick Robert | 0.10% (21130) | OGXI / |
GOLDSTEIN JACK | 0.08% (17500) | ARAY / OGXI / |
Cormack Scott Daniel President and CEO | 0.07% (14810) | OGXI / |
PARKER H STEWART | 0.06% (12500) | OGXI / SGMO / TGEN / |
MARTINO MICHAEL A | 0.05% (11000) | AMBI / OGXI / |
MATTINGLY MARTIN A | 0.05% (10500) | OGXI / |
Smith David V | 0.04% (9500) | CDXS / OGXI / |
Bencich John CFO and PFO | 0.01% (1358) | OGXI / |
Wyrick Susan D. PAO | 0.01% (1312) | OGXI / |